Inhalation compositions comprising glucose anhydrous
US10111957B2 · kind B2 · utility
0Cited by
12References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 27, 2013 |
| Grant date | Oct 30, 2018 |
| Priority date | — |
| Expiry date | Jun 27, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to pharmaceutical powder compositions administered by means of inhalers. More particularly, it relates to pharmaceutical powder compositions having the content uniformity and the desired stability used in inhaler devices.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.